Critically ill patient mortality by age: long-term follow-up (CIMbA-LT)

被引:14
作者
Goncalves-Pereira, Joao [1 ,2 ,3 ]
Oliveira, Andre [1 ]
Vieira, Tatiana [4 ]
Rodrigues, Ana Rita [5 ]
Pinto, Maria Joao [6 ]
Pipa, Sara [7 ]
Martinho, Ana [8 ]
Ribeiro, Sofia [9 ]
Paiva, Jose-Artur [3 ,4 ,10 ]
机构
[1] Hosp Vila Franca Xira, Intens Care Unit, Estr Carlos Lima Costa N2, P-2600009 Vila Franca de Xira, Portugal
[2] Univ Nova Lisboa, Nova Med Sch, Lisbon, Portugal
[3] Grp Invest & Desenvolvimento Infecao & Sepsis GISI, Porto, Portugal
[4] Ctr Hosp Univ S Joao, Intens Care Dept, Porto, Portugal
[5] Ctr Hosp Univ Lisboa Norte, Intens Care Dept, Lisbon, Portugal
[6] Ctr Hosp Tras os Montes & Alto Douro, Intens Care Dept, Vila Real, Portugal
[7] Ctr Hosp Vila Nova Gaia & Espinho, Intens Care Dept, Vila Nova De Gaia, Portugal
[8] Univ Coimbra, Ctr Hosp, Intens Care Dept, Coimbra, Portugal
[9] Univ Algarve, Ctr Hosp, Intens Care Dept, Faro, Portugal
[10] Univ Porto, Fac Med, Porto, Portugal
关键词
Follow-up; Long term; Age; Survival; Mortality; SAPS-II; Standard mortality ratio; INTENSIVE-CARE-UNIT; SAPS-II; ADMISSION; FRAILTY; IMPACT;
D O I
10.1186/s13613-023-01102-3
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundThe past years have witnessed dramatic changes in the population admitted to the intensive care unit (ICU). Older and sicker patients are now commonly treated in this setting due to the newly available sophisticated life support. However, the short- and long-term benefit of this strategy is scarcely studied.MethodsThe Critically Ill patients' mortality by age: Long-Term follow-up (CIMbA-LT) was a multicentric, nationwide, retrospective, observational study addressing short- and long-term prognosis of patients admitted to Portuguese multipurpose ICUs, during 4 years, according to their age and disease severity. Patients were followed for two years after ICU admission. The standardized hospital mortality ratio (SMR) was calculated according to the Simplified Acute Physiology Score (SAPS) II and the follow-up risk, for patients discharged alive from the hospital, according to official demographic national data for age and gender. Survival curves were plotted according to age group.ResultsWe included 37.118 patients, including 15.8% over 80 years old. The mean SAPS II score was 42.8 +/- 19.4. The ICU all-cause mortality was 16.1% and 76% of all patients survive until hospital discharge. The SAPS II score overestimated hospital mortality [SMR at hospital discharge 0.7; 95% confidence interval (CI) 0.63-0.76] but accurately predicted one-year all-cause mortality [1-year SMR 1.01; (95% CI 0.98-1.08)]. Survival curves showed a peak in mortality, during the first 30 days, followed by a much slower survival decline thereafter. Older patients had higher short- and long-term mortality and their hospital SMR was also slightly higher (0.76 vs. 0.69). Patients discharged alive from the hospital had a 1-year relative mortality risk of 6.3; [95% CI 5.8-6.7]. This increased risk was higher for younger patients [21.1; (95% CI 15.1-39.6) vs. 2.4; (95% CI 2.2-2.7) for older patients].ConclusionsCritically ill patients' mortality peaked in the first 30 days after ICU admission. Older critically ill patients had higher all-cause mortality, including a higher hospital SMR. A long-term increased relative mortality risk was noted in patients discharged alive from the hospital, but this was more noticeable in younger patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Long-term mortality and quality of life after septic shock: a follow-up observational study
    Nesseler, Nicolas
    Defontaine, Anne
    Launey, Yoann
    Morcet, Jeff
    Malledant, Yannick
    Seguin, Philippe
    INTENSIVE CARE MEDICINE, 2013, 39 (05) : 881 - 888
  • [32] Critically Ill Elderly Patient Mortality: Is Age a Risk Factor?
    Akin, Sibel
    Gundogan, Kursat
    Coskun, Ramazan
    Yuksel, Recep Civan
    Topaloglu, Ulas Serkan
    Ozturk, Fahir
    Guven, Muhammet
    Sungur, Murat
    JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE, 2014, 5 (02): : 26 - 29
  • [33] Long-term follow-up of patients with candiduria
    Revankar, S. G.
    Hasan, M. S.
    Revankar, V. S.
    Sobel, J. D.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (02) : 137 - 140
  • [34] Long-Term Clinical and Echocardiographic Follow-Up of the Freestyle Stentless Aortic Bioprosthesis
    Mohammadi, Siamak
    Tchana-Sato, Vincent
    Kalavrouziotis, Dimitri
    Voisine, Pierre
    Doyle, Daniel
    Baillot, Richard
    Sponga, Sandro
    Metras, Jacques
    Perron, Jean
    Dagenais, Francois
    CIRCULATION, 2012, 126 (11) : S198 - S204
  • [35] Premature thelarche: A long-term follow-up
    Verrotti, A
    Ferrari, M
    Morgese, G
    Chiarelli, F
    GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (04) : 241 - 247
  • [36] Long-term follow-up for acceptance of silicone testicular prostheses
    Boy, D
    Carl, P
    UROLOGE A, 2002, 41 (05): : 462 - +
  • [37] Very long-term follow-up of living kidney donors
    Fournier, Catherine
    Pallet, Nicolas
    Cherqaoui, Zoubair
    Pucheu, Sylvie
    Kreis, Henri
    Mejean, Arnaud
    Timsit, Marc-Olivier
    Landais, Paul
    Legendre, Christophe
    TRANSPLANT INTERNATIONAL, 2012, 25 (04) : 385 - 390
  • [38] Cylindroma spine metastasis: Long-term follow-up is required
    Riche, M.
    Mathon, B.
    Mokhtari, K.
    Carpentier, A.
    Amelot, A.
    NEUROCHIRURGIE, 2020, 66 (01) : 45 - 49
  • [39] Long-term follow-up of children with retinoblastoma
    Nahum, MP
    Gdal-On, M
    Kuten, A
    Herzl, G
    Horovitz, Y
    Ben Arush, MW
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (03) : 173 - 179
  • [40] Stuve-Wiedemann syndrome: long-term follow-up and genetic heterogeneity
    Jung, C.
    Dagoneau, N.
    Baujat, G.
    Le Merrer, M.
    David, A.
    Di Rocco, M.
    Hamel, B.
    Megarbane, A.
    Superti-Furga, A.
    Unger, S.
    Munnich, A.
    Cormier-Daire, V.
    CLINICAL GENETICS, 2010, 77 (03) : 266 - 272